COL7A1 and recessive dystrophic epidermolysis bullosa: Gene therapy for RDEB has centred primarily on lentiviral gene transfer of a copy of the COL7A1 cDNA, expression of which is governed by exogenous regulatory elements.7,8 While this strategy meets the need for autologous cellular engineering, there are significant hurdles to this approach.